trade practices

As we enter our 5th year, a new look but the same mission for NutriSupLaw

If you have not visited the NutriSupLaw blog in a little while, you should. To celebrate the start of our fifth year, we gave the blog a makeover. Or as they say on the Web, a redesign. We think the new look does a better job of displaying blog entries and organizing our growing lists of resources, links and tags.

Resveratrol marketer on TV again, but not in a good way

This time, the news report is real. We earlier identified News 13 and News 29 as being faux-TV news Web sites that touted the health benefits of resveratrol and acai. Now, CBS News — the real network — is reporting on what appears to be the same Hollywood-based company, FWM Laboratories, in a national broadcast and an accompanying Web story headlined, “Buyer Beware: Web Supplement Scams.”

FDA enforcement action will be swifter, with less notice

The FDA has put supplement companies on notice that violators can expect earlier detection and prosecution. The agency has shifted to a policy of less talk and more action. The industry response must be to get better or get out.

Sunscreen advertising war heats up

GUEST COLUMN by Judith L. Grubner, Esq., Arnstein & Lehr Partner and Intellectual Property Practice Group Leader Some of us remember when parents would chase their children out to play in the sun, with no protection other than play clothes.  Today, the Federal Trade Commission tells us overexposure to the sun’s invisible rays – ultraviolet [...]

Resveratrol marketer hits the Web with faux ‘TV news’

If you thought faux news was the province of only The Daily Show, The Colbert Report and The Onion, welcome to News 13 WKTV. It is the non-TV station, non-news Web site that reports on Resveratrol Ultra. And it is not the only fake station.

Vitamin D at 5,000 IU: Too high, or just too soon?

Some dietary supplement companies are boosting their dosages now. The increases have implications not only for consumer health but for regulatory action. The agency might issue warning letters to companies selling Vitamin D products containing 2.5 times the current UL, telling those manufacturers that their products are potentially unsafe.